Internal Medicine, Hematology & Oncology · Greenbelt, MD
NPI
1407963036
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
7525 Greenway Center Dr, Suite 205
Greenbelt, MD, 20770
Phone (301) 982-9800
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.8M
195,099 services
Medicare patients, 2024
847
Average age 78
Drug cost, 2024
$5.4M
834 prescriptions
Company payments, 2025
$273
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ari D Fishman was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 39,500 times for 47 patients. In total Ari D Fishman billed 195,099 services in 164 codes, and Medicare paid $2.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 39,500 | 47 | $2.30 | $91K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 21,960 | 14 | $38.39 | $843K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 15,750 | 14 | $0.88 | $14K |
| J0897 Injection, denosumab, 1 mg | Office | 8,460 | 29 | $19.93 | $169K |
| J0185 Injection, aprepitant, 1 mg | Office | 4,420 | 13 | $1.31 | $5,778 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 3,070 | 15 | $36.91 | $113K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,300 | 17 | $15.66 | $36K |
| 85025 Blood Count | Office | 1,541 | 506 | $7.60 | $12K |
| 99213 Office E&M - Established | Office | 1,065 | 554 | $73.75 | $79K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,010 | 22 | $0.26 | $263 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 903 | 32 | $0.09 | $80.51 |
| 82784 Immunoassay | Office | 855 | 117 | $9.11 | $7,792 |
| 80053 Clinical Chemistry | Office | 821 | 274 | $10.35 | $8,497 |
| 88185 Surgical Pathology Examination | Office | 683 | 23 | $22.20 | $15K |
| J9395 Injection, fulvestrant, 25 mg | Office | 540 | 12 | $6.49 | $3,503 |
By year: 2022 $2.1M for 181,516 services; 2023 $2.9M for 226,954 services; 2024 $2.8M for 195,099 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,541 | 506 | $7.60 | $12K |
| 82784 Immunoassay | 855 | 117 | $9.11 | $7,792 |
| 80053 Clinical Chemistry | 821 | 274 | $10.35 | $8,497 |
| 88185 Surgical Pathology Examination | 683 | 23 | $22.20 | $15K |
| 83550 Clinical Chemistry | 310 | 156 | $8.57 | $2,657 |
| 83540 Clinical Chemistry | 310 | 156 | $6.34 | $1,965 |
| 83520 Immunoassay | 244 | 105 | $16.92 | $4,128 |
| 82728 Clinical Chemistry | 189 | 89 | $13.36 | $2,525 |
| 36415 Venipuncture Blood Collection | 156 | 123 | $8.65 | $1,349 |
| 82232 Clinical Chemistry | 129 | 49 | $15.86 | $2,046 |
Medicare prescription drug claims, 2024
In 2024, the drug Ari D Fishman prescribed most often to Medicare patients was Eliquis (Apixaban), with 104 prescriptions and refills. In total Ari D Fishman wrote 834 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 104 | 237 | 23 | $134K |
| Hydroxyurea Generic | 80 | 192 | 20 | $1,967 |
| Brukinsa Zanubrutinib | 71 | 71 | Under 11 | $971K |
| Warfarin Sodium Generic | 67 | 176 | 12 | $727 |
| Xarelto Rivaroxaban | 61 | 139 | 16 | $75K |
| Pomalyst Pomalidomide | 54 | 54 | Under 11 | $1.3M |
| Lenalidomide Generic | 39 | 39 | Under 11 | $588K |
| Dexamethasone Generic | 36 | 65 | 15 | $591 |
| Acyclovir Generic | 36 | 60 | Under 11 | $714 |
| Revlimid Lenalidomide | 28 | 28 | Under 11 | $537K |
| Valacyclovir Valacyclovir Hcl | 22 | 26 | Under 11 | $435 |
| Calquence Acalabrutinib Maleate | 22 | 22 | Under 11 | $263K |
| Imbruvica Ibrutinib | 17 | 17 | Under 11 | $270K |
| Jakafi Ruxolitinib Phosphate | 15 | 15 | Under 11 | $259K |
| Thalomid Thalidomide | 14 | 14 | Under 11 | $69K |
Brand drugs: 448 claims; generic drugs: 386 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ari D Fishman $273 ($273 in general payments such as food, travel and fees) from 7 companies. The largest payer was Tempus AI, Inc with $92.18.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.